2024
Trends in Incidence and Survival of Patients with Primary Effusion Lymphoma in the United States
Vaughn J, Epperla N. Trends in Incidence and Survival of Patients with Primary Effusion Lymphoma in the United States. Blood 2024, 144: 5119. DOI: 10.1182/blood-2024-211851.Peer-Reviewed Original ResearchSurvival of patientsPrimary effusion lymphomaOverall survivalAnnual percent changeB symptomsAssociated with HIV infectionEffusion lymphomaTreatment of PELPopulation-based cohort study of patientsRelative survivalCohort study of patientsIncidence rateFive-year OSMedian Follow-UpFive-year RSWorld Health OrganizationPopulation-based cohort studyAge-adjusted incidence ratesCalculate annual percent changesStudy of patientsPatients to clinical trialsTreatment of HIVPeriod of diagnosisFlexible parametric survival modelsDA-EPOCH
2022
Efficacy of neoadjuvant chemotherapy in male breast cancer compared with female breast cancer
Leone JP, Hassett MJ, Leone J, Tolaney SM, Vallejo CT, Leone BA, Winer EP, Lin NU. Efficacy of neoadjuvant chemotherapy in male breast cancer compared with female breast cancer. Cancer 2022, 128: 3796-3803. PMID: 36069365, PMCID: PMC9826058, DOI: 10.1002/cncr.34448.Peer-Reviewed Original ResearchConceptsPathologic complete responseFive-year OSNeoadjuvant chemotherapyMale breast cancerBreast cancerTumor subtypesOverall survivalIndependent associationEfficacy of NACInitiation of NACHuman epidermal growth factor receptor 2Epidermal growth factor receptor 2National Cancer DatabaseGrowth factor receptor 2Multivariable logistic regressionFemale breast cancerFactor receptor 2HR-/HER2Complete responseMedian timeMultivariable analysisKaplan-MeierCancer DatabaseReceptor 2Logistic regressionPotential evidence of peritoneal recurrence in Stage-II colon cancer from the control arm of CALGB9581
Dahdaleh F, Sherman S, Witmer H, Dhiman A, Rajeev R, Poli E, Johnston F, Turaga K. Potential evidence of peritoneal recurrence in Stage-II colon cancer from the control arm of CALGB9581. The American Journal Of Surgery 2022, 224: 459-464. PMID: 35090686, DOI: 10.1016/j.amjsurg.2022.01.017.Peer-Reviewed Original ResearchConceptsDisease-free survivalHigh-risk stateColon cancerPeritoneal metastasisHigh risk of recurrenceStage II colon cancerEarly-stage colon cancerPositive radial marginFive-year OSCurative-intent resectionMedian Follow-UpCox proportional hazards modelsProportional hazards modelCC resectionT4 invasionPeritoneal recurrenceLymphovascular invasionAdjuvant treatmentRadial marginNovel surveillance techniquesTrial patientsCC patientsFollow-upRecurrenceRisk factors
2021
Outcomes of surgically managed primary lung sarcomas: a National Cancer Database analysis
Li AX, Resio BJ, Canavan ME, Papageorge M, Boffa DJ, Blasberg JD. Outcomes of surgically managed primary lung sarcomas: a National Cancer Database analysis. Journal Of Thoracic Disease 2021, 0: 0-0. PMID: 34277037, PMCID: PMC8264694, DOI: 10.21037/jtd-21-1.Peer-Reviewed Original ResearchPrimary lung sarcomaNational Cancer DatabaseLung sarcomaOverall survivalSurgical resectionMultivariable Cox proportional hazards modelsNon-small cell lung cancer patientsNational Cancer Database AnalysisCell lung cancer patientsCox proportional hazards modelCharlson-Deyo scoreFive-year OSMultivariable Cox modelPositive lymph nodesMajority of patientsLung cancer patientsHigh tumor gradeHigh-grade tumorsDifferent histologic subtypesProportional hazards modelAdjuvant chemotherapyParenchymal resectionPulmonary malignancyWorse survivalAdjusted mortality
2019
Retroperitoneal Lymph Node Dissection as Primary Treatment for Men With Testicular Seminoma: Utilization and Survival Analysis Using the National Cancer Data Base, 2004-2014
Tabakin AL, Shinder BM, Kim S, Rivera-Nunez Z, Polotti CF, Modi PK, Sterling JA, Farber NJ, Radadia KD, Parikh RR, Kim IY, Saraiya B, Mayer TM, Singer EA, Jang TL. Retroperitoneal Lymph Node Dissection as Primary Treatment for Men With Testicular Seminoma: Utilization and Survival Analysis Using the National Cancer Data Base, 2004-2014. Clinical Genitourinary Cancer 2019, 18: e194-e201. PMID: 31818649, DOI: 10.1016/j.clgc.2019.10.018.Peer-Reviewed Original ResearchMeSH KeywordsAdolescentAdultFollow-Up StudiesHumansKaplan-Meier EstimateLymph Node ExcisionLymph NodesLymphatic MetastasisMaleMiddle AgedNeoplasm StagingOrchiectomyRegistriesRetroperitoneal SpaceRetrospective StudiesSeminomaSurvival RateTesticular NeoplasmsTestisTreatment OutcomeUnited StatesYoung AdultConceptsRetroperitoneal lymph node dissectionPrimary retroperitoneal lymph node dissectionLymph node dissectionOverall survivalTesticular seminomaNode dissectionRole of RPLNDTesticular nonseminomatous germ cell tumorsNational Cancer Data BaseNonseminomatous germ cell tumorsPrimary testicular cancerFive-year OSFirst-line treatmentKaplan-Meier methodOngoing prospective trialsGerm cell tumorsIIB diseaseOS ratesPrimary chemotherapyPrimary therapyProspective trialFinal cohortStage IIATumor histologyClinical stage
2017
Quantitative pretreatment CT volumetry: Association with oncologic outcomes in patients with T4a squamous carcinoma of the larynx
Shiao J, Mohamed A, Messer J, Hutcheson K, Johnson J, Enderling H, Kamal M, Warren B, Pham B, Morrison W, Zafereo M, Hessel A, Lai S, Kies M, Ferrarotto R, Garden A, Schomer D, Gunn G, Phan J, Frank S, Beadle B, Weber R, Lewin J, Rosenthal D, Fuller C. Quantitative pretreatment CT volumetry: Association with oncologic outcomes in patients with T4a squamous carcinoma of the larynx. Head & Neck 2017, 39: 1609-1620. PMID: 28464542, PMCID: PMC5511768, DOI: 10.1002/hed.24804.Peer-Reviewed Original ResearchConceptsT4a laryngeal cancerSquamous cell carcinomaTumor volumeOverall survivalLaryngeal cancerFive-year overall survivalWorse disease-specific survivalLaryngeal squamous cell carcinomaFive-year OSCause-specific survivalDisease-specific survivalEvent-free survivalIndependent prognostic factorRecurrence-free survivalPrimary tumor volumeSignificant independent correlatesTumor volume measurementsLarynx preservationOncologic outcomesPrognostic factorsPretreatment CTSquamous carcinomaCell carcinomaIndependent correlatesTotal laryngectomy
2014
Prognostic factors in fibrolamellar hepatocellular carcinoma in young people
Darcy D, Malek M, Kobos R, Klimstra D, DeMatteo R, La Quaglia M. Prognostic factors in fibrolamellar hepatocellular carcinoma in young people. Journal Of Pediatric Surgery 2014, 50: 153-156. PMID: 25598114, PMCID: PMC4558902, DOI: 10.1016/j.jpedsurg.2014.10.039.Peer-Reviewed Original ResearchConceptsComplete resectionPRETEXT stageFibrolamellar hepatocellular carcinomaFL-HCCOverall survivalMetastatic diseaseHepatocellular carcinomaAssociated with complete resectionPositive lymph node statusNegative regional lymph nodesFive-year OSAssociated with poor prognosisConsecutive pediatric patientsStage 4 diseaseLymph node statusMedian Follow-UpStage 1 diseaseImpact of resectionRegional lymph nodesParenchymal metastasesN1 diseaseNodal involvementNodal statusRegional lymphadenectomyNode statusImpact of Extent of Surgery on Survival in Patients with Small Nonfunctional Pancreatic Neuroendocrine Tumors in the United States
Gratian L, Pura J, Dinan M, Roman S, Reed S, Sosa JA. Impact of Extent of Surgery on Survival in Patients with Small Nonfunctional Pancreatic Neuroendocrine Tumors in the United States. Annals Of Surgical Oncology 2014, 21: 3515-3521. PMID: 24841347, PMCID: PMC4510956, DOI: 10.1245/s10434-014-3769-4.Peer-Reviewed Original ResearchConceptsNonfunctional pancreatic neuroendocrine tumorsPancreatic neuroendocrine tumorsExtent of surgerySmall Nonfunctional Pancreatic Neuroendocrine TumorsFive-year OSOverall survivalMalignant potentialNeuroendocrine tumorsNational Cancer Data BaseLymph node dissectionLymph node resectionKaplan-Meier analysisType of surgeryLog-rank testUncertain malignant potentialImpact of extentNode dissectionNode resectionTotal pancreatectomyPatient characteristicsRegional lymphRegional lymphadenectomySurgical resectionImproved survivalDistant metastasis
This site is protected by hCaptcha and its Privacy Policy and Terms of Service apply